Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 14, Issue 12, 2012, Pages 1134-1139

  De Ranitz Greven, Wendela L ^a   Kaasenbrood, Lotte ^a   Poucki, Wendy K ^a   Hamerling, Jeanette ^a   Bos, Dieuwke C ^a   Visser, Gerard H A ^a   Biesma, Douwe H ^a   Beulens, Joline W J ^a   De Valk, Harold W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; ADVERSE OUTCOME; ARTICLE; AUTOFLUORESCENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OBSTETRIC PROCEDURE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; SKIN AUTOFLUORESCENCE; SKIN EXAMINATION;

ADULT; DIABETES, GESTATIONAL; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; NETHERLANDS; OPTICAL IMAGING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PROSPECTIVE STUDIES; SKIN;

EID: 84871006499     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0120     Document Type: Article

References (24)

1. Goh SY, Cooper ME: Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143-1152.
2. Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A: Pimple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005;1043: 290-298.
3. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Pimple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330.
4. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ: Pkin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693.
5. Bos DC, de Ranitz-Greven WL, de Valk HW: Advanced glycation end products, measured as skin autofluorescence and diabetes complications: A systematic review. Diabetes Technol Ther 2011;13:773-779.
6. Chabroux S, Canoui-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, Thivolet C: Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab 2010;36:152-157.
7. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Pkin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31:517-521.
8. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ: Pkin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 200629:2654-2659.
9. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ: Pkin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009;52:789-797.
10. Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, Gans RO, Smit AJ: Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005;48:1637-1644.
11. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Pkin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112.
12. Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E: Pkin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract 2008;79:56-60.
13. de Ranitz-Greven WL, Bos DC, Poucki WK, Visser GH, Beulens JW, Biesma DH, de Valk HW: Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy. Diabetes Technol Ther 2012;14:43-49.
14. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM: Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications participants with type 1 diabetes. Diabetes 2005;54:3103-3111.
15. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ: Pkin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: An overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006;8: 523-535.
16. Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM: New Dutch reference curves for birthweight by gestational age. Early Hum Dev 2009;85:737-744.
17. Blaauw J, Smit AJ, Van Pampus MG, Van Doormaal JJ, Aarnoudse JG, Rakhorst G, Graaff R: Pkin autofluorescence, a marker of advanced glycation end products and oxidative stress, is increased in recently preeclamptic women. Am J Obstet Gynecol 2006;195:717-722.
18. Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS: Pcreening for gestational diabetes: The effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol 2007;47:307-312.
19. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
20. Carlin A, Alfirevic Z: Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol 2008; 22:801-823.
21. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836-842.
22. Noordzij MJ, Lefrandt JD, Smit AJ: Advanced glycation end products in renal failure: An overview. J Ren Care 2008; 34:207-212.
23. Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ: Pkin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J 2009;17: 162-168.
24. Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ: Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther 2011;13:165-170.